table of content
1 Study Coverage
1.1 Opioid Induced Constipation (OIC) Drugs Product Introduction
1.2 Global Opioid Induced Constipation (OIC) Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume for the Year 2017-2028
1.3 United States Opioid Induced Constipation (OIC) Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Opioid Induced Constipation (OIC) Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Opioid Induced Constipation (OIC) Drugs Sales in Volume for the Year 2017-2028
1.4 Opioid Induced Constipation (OIC) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Opioid Induced Constipation (OIC) Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Opioid Induced Constipation (OIC) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Opioid Induced Constipation (OIC) Drugs Market Dynamics
1.5.1 Opioid Induced Constipation (OIC) Drugs Industry Trends
1.5.2 Opioid Induced Constipation (OIC) Drugs Market Drivers
1.5.3 Opioid Induced Constipation (OIC) Drugs Market Challenges
1.5.4 Opioid Induced Constipation (OIC) Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Opioid Induced Constipation (OIC) Drugs Market Segment by Type
2.1.1 Lubiprostone
2.1.2 Methyl Naltrexone Bromide
2.1.3 Naldemedine
2.1.4 Alvimopan
2.1.5 Others
2.2 Global Opioid Induced Constipation (OIC) Drugs Market Size by Type
2.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Opioid Induced Constipation (OIC) Drugs Market Size by Type
2.3.1 United States Opioid Induced Constipation (OIC) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Opioid Induced Constipation (OIC) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Opioid Induced Constipation (OIC) Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Opioid Induced Constipation (OIC) Drugs Market Size by Application
3.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Opioid Induced Constipation (OIC) Drugs Market Size by Application
3.3.1 United States Opioid Induced Constipation (OIC) Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Opioid Induced Constipation (OIC) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Opioid Induced Constipation (OIC) Drugs Competitor Landscape by Company
4.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Company
4.1.1 Top Global Opioid Induced Constipation (OIC) Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Opioid Induced Constipation (OIC) Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Opioid Induced Constipation (OIC) Drugs Price by Manufacturer (2017-2022)
4.2 Global Opioid Induced Constipation (OIC) Drugs Concentration Ratio (CR)
4.2.1 Opioid Induced Constipation (OIC) Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Opioid Induced Constipation (OIC) Drugs in 2021
4.2.3 Global Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Opioid Induced Constipation (OIC) Drugs Market Size by Company
4.5.1 Top Opioid Induced Constipation (OIC) Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Opioid Induced Constipation (OIC) Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Opioid Induced Constipation (OIC) Drugs Sales by Players (2020, 2021 & 2022)
5 Global Opioid Induced Constipation (OIC) Drugs Market Size by Region
5.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Opioid Induced Constipation (OIC) Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Opioid Induced Constipation (OIC) Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Ironwood Pharmaceuticals Inc
7.1.1 Ironwood Pharmaceuticals Inc Corporation Information
7.1.2 Ironwood Pharmaceuticals Inc Description and Business Overview
7.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
7.1.5 Ironwood Pharmaceuticals Inc Recent Development
7.2 Daiichi Sankyo Co Ltd
7.2.1 Daiichi Sankyo Co Ltd Corporation Information
7.2.2 Daiichi Sankyo Co Ltd Description and Business Overview
7.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
7.2.5 Daiichi Sankyo Co Ltd Recent Development
7.3 Pfizer
7.3.1 Pfizer Corporation Information
7.3.2 Pfizer Description and Business Overview
7.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Products Offered
7.3.5 Pfizer Recent Development
7.4 Progenics Pharmaceuticals Inc
7.4.1 Progenics Pharmaceuticals Inc Corporation Information
7.4.2 Progenics Pharmaceuticals Inc Description and Business Overview
7.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
7.4.5 Progenics Pharmaceuticals Inc Recent Development
7.5 Shionogi & Co., Ltd
7.5.1 Shionogi & Co., Ltd Corporation Information
7.5.2 Shionogi & Co., Ltd Description and Business Overview
7.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
7.5.5 Shionogi & Co., Ltd Recent Development
7.6 Allergan Plc
7.6.1 Allergan Plc Corporation Information
7.6.2 Allergan Plc Description and Business Overview
7.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Products Offered
7.6.5 Allergan Plc Recent Development
7.7 Nektar Therapeutics
7.7.1 Nektar Therapeutics Corporation Information
7.7.2 Nektar Therapeutics Description and Business Overview
7.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Products Offered
7.7.5 Nektar Therapeutics Recent Development
7.8 Purdue Pharma
7.8.1 Purdue Pharma Corporation Information
7.8.2 Purdue Pharma Description and Business Overview
7.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Products Offered
7.8.5 Purdue Pharma Recent Development
7.9 S.L.A. Pharma AG
7.9.1 S.L.A. Pharma AG Corporation Information
7.9.2 S.L.A. Pharma AG Description and Business Overview
7.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Products Offered
7.9.5 S.L.A. Pharma AG Recent Development
7.10 Mundipharma International Limited
7.10.1 Mundipharma International Limited Corporation Information
7.10.2 Mundipharma International Limited Description and Business Overview
7.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Products Offered
7.10.5 Mundipharma International Limited Recent Development
7.11 Ono Pharmaceutical Co., Ltd
7.11.1 Ono Pharmaceutical Co., Ltd Corporation Information
7.11.2 Ono Pharmaceutical Co., Ltd Description and Business Overview
7.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
7.11.5 Ono Pharmaceutical Co., Ltd Recent Development
7.12 Takeda Pharmaceutical Company Limited
7.12.1 Takeda Pharmaceutical Company Limited Corporation Information
7.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview
7.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Takeda Pharmaceutical Company Limited Products Offered
7.12.5 Takeda Pharmaceutical Company Limited Recent Development
7.13 Theravance Biopharma Inc
7.13.1 Theravance Biopharma Inc Corporation Information
7.13.2 Theravance Biopharma Inc Description and Business Overview
7.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Theravance Biopharma Inc Products Offered
7.13.5 Theravance Biopharma Inc Recent Development
7.14 Bausch Health
7.14.1 Bausch Health Corporation Information
7.14.2 Bausch Health Description and Business Overview
7.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Bausch Health Products Offered
7.14.5 Bausch Health Recent Development
7.15 Cosmo Pharmaceuticals SA
7.15.1 Cosmo Pharmaceuticals SA Corporation Information
7.15.2 Cosmo Pharmaceuticals SA Description and Business Overview
7.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Cosmo Pharmaceuticals SA Products Offered
7.15.5 Cosmo Pharmaceuticals SA Recent Development
7.16 Daewoong Pharmaceutical
7.16.1 Daewoong Pharmaceutical Corporation Information
7.16.2 Daewoong Pharmaceutical Description and Business Overview
7.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Daewoong Pharmaceutical Products Offered
7.16.5 Daewoong Pharmaceutical Recent Development
7.17 C.B. Fleet Company
7.17.1 C.B. Fleet Company Corporation Information
7.17.2 C.B. Fleet Company Description and Business Overview
7.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 C.B. Fleet Company Products Offered
7.17.5 C.B. Fleet Company Recent Development
7.18 Sucampo Pharmaceuticals
7.18.1 Sucampo Pharmaceuticals Corporation Information
7.18.2 Sucampo Pharmaceuticals Description and Business Overview
7.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Sucampo Pharmaceuticals Products Offered
7.18.5 Sucampo Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Opioid Induced Constipation (OIC) Drugs Industry Chain Analysis
8.2 Opioid Induced Constipation (OIC) Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Opioid Induced Constipation (OIC) Drugs Distributors
8.3 Opioid Induced Constipation (OIC) Drugs Production Mode & Process
8.4 Opioid Induced Constipation (OIC) Drugs Sales and Marketing
8.4.1 Opioid Induced Constipation (OIC) Drugs Sales Channels
8.4.2 Opioid Induced Constipation (OIC) Drugs Distributors
8.5 Opioid Induced Constipation (OIC) Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
